Navigation Links
Veteran of the Beverage Industry, Ken Sadowsky, Joins Millennium Biotechnologies Board of Directors
Date:9/17/2008

BASKING RIDGE, N.J., Sept. 17 /PRNewswire-FirstCall/ -- Millennium Biotechnologies Group, Inc. (OTC Bulletin Board: MBTG) today announced that veteran beverage industry expert, Ken Sadowsky, has joined the Board of Directors.

Mr. Sadowsky is currently the Executive Director of NIDA, an association of independent distributors from Maine to New Jersey who have significant purchasing and distribution power. Previously, he was a principal of the beverage distribution company, Atlas Distributing of Auburn, Massachusetts. As a prominent beverage distributor in the northeast, he has been credited for foreseeing the market shift away from carbonated beverages with his early adoption of such brands as Snapple Beverages and SoBe. Mr. Sadowsky served on the Board of Directors of Energy Brands, Inc. (Glaceau) makers of Glaceau, VitaminWater, SmartWater and FruitWater from 2000 to 2006 when Glaceau sold a minority interest to The Tata Group. Glaceau was later was sold to Coca Cola (NYSE: KO) for $4.1 Billion. Mr. Sadowsky is considered an expert in the field of non-alcoholic and functional beverages and has been featured in numerous industry and branding publications. He presently collaborates with Verlinvest L.L.C., a Belgium based investment fund with global interest in the worldwide beverage market and one of Europe's largest owners of nursing home facilities.

"We are actively restructuring our Board of Directors to add individuals whose capabilities are more clearly aligned with the new direction of the Company, including exploring and implementing transactions that would quickly increase shareholder value. Ken is the first member of our new board and his pre-eminent industry relations give us a valuable asset in highlighting our position in the marketplace. It is both a privilege and honor to work with him," commented Mark Mirken, CEO of Millennium Biotechnologies.

"Since my initial introduction to Company's line of functional beverages, I have come to understand its unique qualities and verifiable medical credentials. The Company's intellectual property and independent studies give it permission to make medically supportable claims currently unmatched in this market. It is these qualifications that uniquely position it in the rapidly growing functional beverages and meal replacement category. I look forward to working with the Company in leveraging this technology for the benefit of its shareholders and believe that numerous broad-based opportunities exist in the near term," stated Mr. Sadowsky.

About Millennium

Millennium's six marketed products form its advanced line of nutritional formulas. Resurgex Select(R) is a whole foods-based, calorically dense, high-protein nutritional formula developed for cancer patients undergoing chemotherapy or radiation treatments. Resurgex(R) and Resurgex Plus(R) are specialized, anabolic nutritional supplements rich in antioxidants that provide nutritional support post-treatment. Millennium also created Surgex(TM) sports nutrition formula to address the nutritional concerns of professional, Olympic, and amateur elite athletes. These athletes often experience similar symptoms post-workout to those battling immuno-compromised conditions, such as fatigue, loss of lean muscle, oxidative stress, and reduced immune function. Resurgex Essential(TM) and Resurgex Essential Plus(TM) are comprehensive, calorically dense formulas that meet and succeed the nutritional requirements of the assisted living community.

Statements in this news release regarding future financial and operating results, future growth in R&D programs, potential applications of the Millennium's technology, opportunities for the Millennium, and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words 'will,' 'believes,' 'plans,' 'anticipates,' 'expects,' 'estimates,' and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward- looking statements including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of Millennium's intellectual property, and economic conditions generally. Additional information on potential factors that could affect results and other risks and uncertainties are detailed from time to time in Millennium's periodic reports, including Forms 10-KSB, 10-QSB, 8-K, and other forms filed with the Securities and Exchange Commission ('SEC'). Millennium Biotechnologies, Inc.


'/>"/>
SOURCE Millennium Biotechnologies Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Healthcare Veteran Richard Findlay Joins Diamond Management & Technology Consultants as Partner
2. The American Liver Foundation Appoints Rick Smith, a Twenty-Year Veteran of The MS Society, as Chief Executive Officer
3. Easter Seals Launches Program for Veterans Returning from Iraq and Afghanistan with Traumatic Brain Injuries
4. Fundraiser Announced for Morongo Fire Chief; Veteran Firefighter Diagnosed With ALS
5. Lilly Grant to VA Will Enhance Services for Returning Combat Veterans
6. The Jericho Project Announces Rehabilitation Residence for Homeless and Low-Income Veterans
7. Mismanagement at North Florida/South Georgia Veterans Health System Results in Chronic Staff Shortages, Budget Issues
8. Younger Veterans at Greater Suicide Risk
9. Key findings for all veterans seen in depression and suicide study
10. Knights of Columbus to Distribute Wheelchairs to Veterans in Need
11. Chicago Bears Players Visit Hospitalized Veterans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... DC (PRWEB) , ... April 24, 2017 , ... The ... recognized during ATA 2017: Telehealth 2.0 — the American Telemedicine Association’s annual conference, on ... Santana Telehealth Project for using telemedicine to improve the lives of the poor and ...
(Date:4/24/2017)... IL (PRWEB) , ... April 24, 2017 , ... Today, Bright Pink , a ... in young women, names a new CEO. , Bright Pink is proud to announce ... she would be moving to a new role as Chairman of the Board and ...
(Date:4/24/2017)... Raton, Florida (PRWEB) , ... April 24, 2017 ... ... develops a variety of unique liquid food supplements, announced its popular products are ... nutritional products. , ALP Nutrition® prioritizes the use of premium natural ingredients ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... (CDC), rising prescription opioid overdose deaths now claim the lives of 62 Americans ... civil case filings against drug manufacturers, distributors, pharmacies and prescribers by more than ...
(Date:4/24/2017)... ... 24, 2017 , ... As a former supermodel known for her timeless beauty, ... for single women is that she put all the words in her new book, ... insight, personal experiences and sparkling sense of humor have inspired her to write a ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, ... their offering. ... pharmacogenomics market was valued at US$ 7,167.6 Mn in 2015, ... expanding at a CAGR of 5.6% from 2016 to 2024. ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), ... Forecasts, 2014 - 2025" report to their offering. ... The Latin American pharmaceutical ... billion by 2025 Low drug registration cost in ...
(Date:4/19/2017)... , April 19, 2017 The Mobile X-Ray product ... a healthy CAGR during the forecast period Mobile ... the global digital mobile X-Ray devices market, which is estimated ... 2017, expanding at a CAGR of 7% over the forecast ... opportunity of more than US$ 100 Mn in 2017 over ...
Breaking Medicine Technology: